Beyond the Brain Map: Why Adding ERP Can Improve Neurotherapy Assessment and Protocol Development

A quantitative EEG (qEEG) can provide a remarkable amount of information about how the brain is functioning. By examining electrical activity recorded from the scalp, we can evaluate patterns of brainwave activity, regional differences, connectivity, and the balance between slower and faster frequencies.

But there is an important limitation: most traditional qEEG recordings tell us primarily what the brain is doing at rest.

Event-Related Potentials (ERPs) add another dimension. Rather than simply asking, “What does this brain look like while resting?”, an ERP assessment asks:

“What happens when this brain has to do something?”

That distinction can be particularly valuable when developing individualized neurotherapy strategies.

qEEG and ERP: Two Different Windows Into Brain Function

A resting qEEG is typically recorded while a person sits quietly with their eyes closed and eyes open. The EEG can then be analyzed for features such as:

• Delta, theta, alpha and beta activity

• Peak alpha frequency

• Regional differences in brain activity

• Functional connectivity and network relationships

• Patterns of unusually high or low activity

• Differences between eyes-open and eyes-closed states

• 
  

These measurements provide information about the brain's ongoing or spontaneous electrical activity.

ERPs are derived from EEG as well, but they are measured while the individual performs a structured cognitive task. During an ERP assessment, stimuli are presented repeatedly while the EEG records the brain's responses. Those responses are precisely aligned to the timing of the stimulus and averaged across many trials. This allows very small but consistent neural responses to emerge from the background EEG.

The result is a millisecond-by-millisecond view of how the brain processes information.

EEG and ERP therefore provide complementary information: EEG characterizes ongoing neural activity, while ERP measures neural responses associated with specific sensory, attentional and cognitive events.

Seeing the Brain in Action

Consider someone who reports difficulty concentrating.

Their resting qEEG might reveal elevated slow-wave activity, excessive fast activity, altered connectivity—or perhaps very little that clearly explains the difficulty.

An ERP attention task can examine what happens when that person's brain must:

notice a stimulus → distinguish its importance → inhibit irrelevant information → make a decision → respond.

Different ERP components occur at different points in this sequence.

Early components can reflect sensory registration and initial attention. Later components provide information about higher-order processes such as stimulus evaluation, attention allocation, working memory and decision-making.

One of the best-known is the P300, a positive electrical response generally occurring several hundred milliseconds after a meaningful or task-relevant stimulus.

The P300 has been extensively investigated in conditions involving attention and cognitive processing, including ADHD. Differences in P300 amplitude and latency have also been associated with treatment response in some studies.

This does not mean that a P300 result diagnoses ADHD—or any other disorder. Rather, it provides an additional physiological measure of how efficiently certain cognitive processes are occurring.

Why Timing Matters

The brain operates extremely quickly.

Two people may ultimately give the correct answer on a cognitive task, yet their brains may have arrived at that answer very differently.

One person's brain may identify the relevant information rapidly and efficiently.

Another person's brain may require substantially more time or neural resources to accomplish the same task.

Because ERPs measure electrical activity on the scale of milliseconds, they can reveal differences that may not be obvious from behavioural performance alone. This temporal resolution is one of the major strengths of EEG and ERP methodology.

This becomes particularly interesting in neurotherapy because the question is no longer simply:

“Where is the abnormal brainwave activity?”

It becomes:

“At what stage of information processing does this brain appear to be struggling?”

ERP Can Help Clarify an Ambiguous qEEG

This is one of the reasons we have increasingly found ERP information useful when interpreting complex brain maps.

Suppose a qEEG shows increased theta activity in frontal regions.

That finding might be relevant to attention—but theta activity itself does not tell us precisely what cognitive process is impaired. Depending upon the individual and context, theta can participate in many normal and abnormal neural processes.

If the ERP assessment simultaneously demonstrates delayed or reduced responses during attentional processing, the two findings together provide a more coherent picture.

Conversely, the ERP may be relatively intact.

That information matters too.

It reminds us that an unusual EEG finding is not automatically evidence of impaired cognitive function.

In other words, ERP can sometimes help us decide which qEEG findings deserve the greatest clinical attention—and which may simply represent individual variation.

Looking Beyond Symptoms

Many neurological and psychological conditions share similar symptoms.

Poor concentration, for example, can occur with ADHD, anxiety, depression, sleep deprivation, concussion, chronic stress, medication effects and many other circumstances.

The symptom is real, but the underlying neurophysiology may be quite different.

Research across psychiatric and neurological populations has demonstrated abnormalities in both resting EEG and ERP measures, which is one reason investigators increasingly explore combinations of electrophysiological biomarkers rather than relying upon a single measurement. citeturn0search6turn0search10

This approach fits well with individualized neurotherapy.

Rather than starting with a diagnosis and assuming that everyone with that diagnosis requires the same protocol, assessment can begin with a different question:

What appears to be happening in this particular person's brain?

ERP May Also Help Us Measure Change

Another interesting application is repeating ERP measures after an intervention.

Symptom questionnaires are extremely important, but they are inherently subjective. A person may feel significantly better while some cognitive vulnerabilities remain—or physiological improvements may begin before the individual clearly recognizes them.

ERP measures potentially provide another objective way of examining change.

Research has demonstrated that ERP measures can change following pharmacological and behavioural interventions, and ERP changes have also been investigated following neurofeedback training. citeturn0search11turn0search4

For neurotherapy, this raises an intriguing possibility.

Instead of asking only:

“Did the brainwave pattern change?”

we can also ask:

“Did the brain become more efficient at processing information?”

Those are related questions, but they are not identical.

A More Complete Neurophysiological Picture

Neither qEEG nor ERP should be interpreted in isolation.

EEG findings must be considered alongside symptoms, history, medications, sleep, previous injuries, psychological factors and other relevant clinical information. ERP findings require the same caution.

ERP is also not a stand-alone diagnostic test for conditions such as ADHD, anxiety, depression, concussion or dementia.

Its value lies in adding another piece to the puzzle.

A useful way of thinking about the distinction is:

qEEG tells us about the brain's electrical environment.

ERP tells us how that brain responds when information arrives and has to be processed.

When those two perspectives are considered together—alongside the person's history and lived experience—we can develop a much richer understanding of brain function.

For neurotherapy protocol development, that additional information can help identify which findings are most clinically meaningful, clarify potential treatment targets, and provide physiological measures that can potentially be followed over time.

Ultimately, the goal is not to collect more data simply because we can.

The goal is to collect better information that helps us make more thoughtful and individualized decisions.

References

Fietz, J., Auer, G., Plener, P., et al. (2025). Empathy and event related potentials before and after EEG based neurofeedback training in autistic adolescents. Scientific Reports, 15, 30824. https://doi.org/10.1038/s41598-025-16767-y

Kim, J. S. (2021). What event-related potential tells us about brain function. Translational Neuroscience, 12, 153–162.

Mumtaz, W., Xia, L., Yasin, M. A. M., Ali, S. S. A., & Malik, A. S. (2015). A review on EEG and ERP predictive biomarkers for major depressive disorder. Biomedical Signal Processing and Control, 22, 85–98.

Peisch, V., Rutter, T., Wilkinson, C. L., & Arnett, A. B. (2021). Sensory processing and P300 event-related potential correlates of stimulant response in children with attention-deficit/hyperactivity disorder: A critical review. Clinical Neurophysiology, 132(4), 953–966.

Walla, P. (2025). The power of time: Advantages of electroencephalography (EEG) and event-related potentials (ERPs) in affective and cognitive neuroscience. Brain Sciences.

Williams, L. M., et al. Research literature on electrophysiological biomarkers and cognitive processing across psychiatric conditions.

Important note: qEEG and ERP findings are best regarded as complementary physiological information. They should not be used independently to establish psychiatric or neurological diagnoses, and their interpretation should always be integrated with clinical history, symptoms and other appropriate assessments.